Merck (MRK) Intangibles (2009 - 2026)
Merck (MRK) reported Intangibles of $24.98 billion for Q2 2026, up 64.4% from $15.19 billion a year earlier but down 3.0% from the prior quarter.
Powered by 
Analysis
Merck (MRK) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Merck posted Intangibles of $26.68 billion, up 63.0% from FY2024.
- Intangibles has a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- By year, Intangibles came in at $16.37 billion in FY2024 (-9.1%), $18.01 billion in FY2023 (-11.1%), $20.27 billion in FY2022 (-11.6%) and $22.93 billion in FY2021 (+62.6%).
- Five-year quarterly Intangibles spans a low of $13.38 billion in Q3 2021 and a high of $26.68 billion in Q4 2025.
- Year over year, Intangibles has now increased in each of the last three quarters, with growth averaging 17.4% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was Q2 2022 (growth of 65.2%); the low point was Q3 2021 (a decline of 19.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.75 billion (Q1 2026), $26.68 billion (Q4 2025) and $15.31 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 17.39 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.98 Bn |
| Mar 31, 2026 | 25.75 Bn |
| Dec 31, 2025 | 26.68 Bn |
| Sep 30, 2025 | 15.31 Bn |
| Jun 30, 2025 | 15.19 Bn |
| Mar 31, 2025 | 15.76 Bn |
| Dec 31, 2024 | 16.37 Bn |
| Sep 30, 2024 | 17.01 Bn |
| Jun 30, 2024 | 16.98 Bn |
| Mar 31, 2024 | 17.57 Bn |
| Dec 31, 2023 | 18.01 Bn |
| Sep 30, 2023 | 19.20 Bn |
| Jun 30, 2023 | 19.67 Bn |
| Mar 31, 2023 | 19.86 Bn |
| Dec 31, 2022 | 20.27 Bn |
| Sep 30, 2022 | 21.37 Bn |
| Jun 30, 2022 | 22.50 Bn |
| Mar 31, 2022 | 23.02 Bn |
| Dec 31, 2021 | 22.93 Bn |
| Sep 30, 2021 | 13.38 Bn |
API Access
Merck Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();